TheraRadar
Company Portfolios →

Hansoh BioMedical R&D Company

35 active trials across 4 therapeutic areas

35
Active Trials
17
Phase 1
13
Phase 2
8
Phase 3
4
Therapeutic Areas
Portfolio Concentration: 89% of active trials in Oncology

Oncology

31 active / 32 total
Solid Tumor (Advanced)
12 active
12 total since 2015
NSCLC
4 active 2 Ph3
4 total since 2015
Colorectal Cancer
3 active
3 total since 2015
Sarcoma
3 active 1 Ph3
3 total since 2015
Ovarian Cancer
2 active 1 Ph3
2 total since 2015
Prostate Cancer
2 active
2 total since 2015
SCLC
1 active 1 Ph3
2 total since 2015
MDS
1 active
1 total since 2015
Endometrial Cancer
1 active
1 total since 2015
Head and Neck Cancer
1 active
1 total since 2015
Lung Cancer (General)
1 active 1 Ph3
1 total since 2015

Immunology

6 active / 7 total
Psoriasis
3 active 2 Ph3
4 total since 2015
Ankylosing Spondylitis
2 active
2 total since 2015
Psoriatic Arthritis
1 active
1 total since 2015

CNS

2 active / 2 total
Multiple Sclerosis
2 active
2 total since 2015

Cardiovascular

1 active / 1 total
Myocardial Infarction
1 active
1 total since 2015

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)